Early-Career Investigators Showcase (2020)

Available on Saturday, July 11:

This on-demand webcast is dedicated to the work of some of the best and brightest new investigators in urology, showcasing their discoveries in high-impact basic, translational, and clinical research. Participants are nominated by AUA Sections, sub-specialty societies, or members of the AUA Board of Directors or AUA Research Council and Committees. Ten nominees have been selected by a peer-review panel to present their research via webcast presentations, and digital scientific posters from all nominees are available for viewing.

Registration Fees

Member Category

 

AUA MemberFree
AUA Non-MemberFree

Target Audience

  • Physician scientists
  • Researchers
  • Clinical fellows
  • Postdoctoral fellows
  • Residents
  • Medical/graduate students

Course summary
Course opens: 
05/29/2020
Course expires: 
07/10/2023
Parent activity set: 
Rating: 
0

Presentations

Welcome and IntroductionsCarolyn J.M. Best, PhD
Director of Research, American Urological Association
An Investigation of the Physiology of Ureteral Contraction and the Adverse Effects of Stent PlacementKymora B. Scotland, MD, PhD
University of California Los Angeles
Abiraterone and enzalutamide are less effective when administered after long-term androgen deprivation therapy in a novel castration-resistant prostate cancer cellular model.Ignacio Puche-Sanz, MD, PhD
Hospital Universitario Virgen de las Nieves, Spain
Testosterone and Estrogen Supplementation Reverse Urethral Atrophy in Hypogonadal RatsMatthias D. Hofer, MD, PhD
Northwestern University
Molecular Subtype in MIBC is Driven by Sex-Specific DifferencesSima P. Porten, MD, MPH, FACS
University of California San Francisco
CHD1-loss Promotes Tumor Heterogeneity and Antiandrogen ResistancePing Mu, PhD
University of Texas Southwestern
Phosphatidylserine as a Biomarker of Sperm Vitality and Fertilization CompetencyRyan P. Smith, MD
University of Virginia
Assessing the impact of telehealth insurance reform on telehealth utilizationChad Ellimoottil, MD, MS
University of Michigan
Disparities in Use of Pre-Biopsy Prostate MRI for Medicare-Eligible Prostate Cancer PatientsChristopher P. Filson, MD, MS
Emory University
Employing Multiparametric Profiling to Characterize Immunotherapy Responders in Clear Cell Renal Cell CarcinomaBrandon J. Manley, MD
Moffitt Cancer Center

Digital Posters

Polymorphisms in the SLC13A2 (NaDC1) and SLC13A3 (NaDC3) genes in patients with kidney stonesMario Basulto-Martinez, MD, MSc
Hospital Regional de Alta Especialidad de la Peninsula de Yucatan, Mexico
Access to Care is a Key Determinant for Race-Based Differences in Prostate Cancer OutcomesAlexander P. Cole, MD
Brigham and Women’s Hospital
Assessing the impact of telehealth insurance reform on telehealth utilizationChad Ellimoottil, MD, MS
University of Michigan
Disparities in Use of Pre-Biopsy Prostate MRI for Medicare-Eligible Prostate Cancer PatientsChristopher P. Filson, MD, MS
Emory University
Testosterone and Estrogen Supplementation Reverses Urethral Atrophy in Hypogonadal RatsMatthias D. Hofer, MD, PhD
Northwestern University
KDM6A acts as a tumor suppressor in bladder cancer by functioning as a co‐activator for FOXA1Byron H. Lee, MD, PhD
Cleveland Clinic
Gender Impact on Bladder-Related Outcomes and Quality of Life after Paraplegic Spinal Cord InjurySara M. Lenherr, MD, MS, FPMRS
University of Utah
Reconnaissance of Tumor Immune Microenvironment Spatial Heterogeneity in Metastatic Clear Cell Renal Cell Carcinoma and Correlation with Response to ImmunotherapyBrandon J. Manley, MD
Moffitt Cancer Center
Loss of CHD1 Promotes Cancer Heterogeneity and Lineage Plasticity to Escape AR Targeted Therapy in Metastatic Prostate CancerPing Mu, PhD
University of Texas Southwestern
Quantification of Personalized Risk and Resilience in Patients with Bladder CancerSarah P. Psutka, MD, MSc
University of Washington
Abiraterone and enzalutamide are less effective when administered after long-term androgen deprivation therapy in a novel castration-resistant prostate cancer cellular model.Ignacio Puche-Sanz, MD, PhD
Hospital Universitario Virgen de las Nieves, Spain
Posphatidylserine (PtdSer) as a Biomarker of Sperm Vitality and Fertilization CompetencyRyan P. Smith, MD
University of Virginia
Implementing a Fast Track Pathway for Microscopic Hematuria Referrals to the Urology DepartmentKara L. Watts, MD
Montefiore Medical Center
Please login or register to take this course.